BMS program

 

BMS meeting. 

 Robert Bruno, 3D bioprint and cancer

 Lifang Yang

 Larry Sanford

 Frank Lattanzio

 Patrick Sachs

 Siqi Guo

 Ebony Clark

 Lisa Shollengerger

 Peter Mollica

• Lifang Yang: Focuses on fundamental and translational cancer research, specifically cancer pathogenesis, biomarker development, and therapeutic approaches. Her lab studies tumor cells, tumor microenvironment, extracellular vesicles, proteomics, and cancer disparities to advance precision oncology through multi-omics and bioinformatics approaches.
• Frank Lattanzio: Connected to bioelectrics research, including applications of nanosecond pulsed electric fields (nsPEFs) in cancer treatment and cellular electropermeabilization mechanisms.
• Patrick Sachs: Associated with biomedical and translational sciences, likely focusing on biomedical engineering and tumor microenvironment studies combined with 3D bioprinting and cancer research models.
• Siqi Guo: Involved in bioelectric research, including DNA vaccination delivery, electrotransfer, and electroporation-mediated gene transfer techniques; associated with cellular and molecular response to electric fields.

• Siqi Guo is a Research Associate Professor affiliated with the Frank Reidy Research Center for Bioelectrics. His grants include a commercial contract worth about $102,900 (2016-2017) for studying nanosecond electric pulses (NSEPS) as an ablation-immunotherapy for advanced pancreatic cancer. His work focuses on cancer, biotechnology, and bioelectric therapies like nano-pulse stimulation and gene electrotransfer for cancer treatment. He leads projects advancing novel immunotherapy techniques based on electric pulse technology.
• Lifang Yang, listed as an instructor at Eastern Virginia Medical School collaborating with ODU, shares in recent multidisciplinary seed funding ($42,000) supporting research on synergistic effects of nano-pulse treatment combined with cold plasma reactive species for cancer treatment. Her expertise centers on cancer pathogenesis, tumor microenvironment, extracellular vesicles, and biomarker discovery aiming to improve precision oncology through multi-omics and bioinformatics.